Brief: Beijing Biostar Pharmaceuticals Says To Grant Baheal Zhihe Exclusive Marketing Rights
14/11/2024 10:36
Nov 14 (Reuters) - Beijing Biostar Pharmaceuticals Co
Ltd 2563.HK :
* TO GRANT BAHEAL ZHIHE EXCLUSIVE RIGHT TO PROVIDE MARKETING
SERVICE FOR UTIDELONE INJECTION
* BEIJING BAHEAL ZHIHE MEDICAL ACHIEVEMENT TRANSFORMATION
SERVICE
TO PAY CO DOWN PAYMENT OF RMB50 MILLION
Further company coverage: 2563.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beijing Biostar Pharmaceuticals
See all newsBrief: Beijing Biostar Pharmaceuticals To Issue 25 MLN New Shares At HK$4.00 Per Share
Brief: Beijing Biostar Pharmaceuticals Says Board Resolves To Repurchase H Shares In Open Market
Brief: Beijing Biostar Pharmaceuticals Posts FY Loss Attributable RMB131.4 Mln
Brief: FDA Grants Orphan Drug Designation To Biostar Pharma's Utidelone
Brief: Biostar Pharma Doses First Patients In Two Phase II/III Global Trials Of Utidelone Capsule (UTD2) For Cancer